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INTRODUCTION
Colorectal stenting is well known to be effective and safe 
in relieving obstructions, either palliatively or as a bridge 
Dual-Design Expandable Colorectal Stent for a Malignant 
Colorectal Obstruction: Preliminary Prospective Study 
Using New 20-mm Diameter Stents
Sandas Qi Hua Chou, MBBS
1, 2, Ho-Young Song, MD
1, Jin Hyoung Kim, MD
1, Jung-Hoon Park, RT
1, 
Yong Fan, MD
1, Heuiran Lee, PhD
3, Yong Sik Yoon, MD
4, Jin Cheon Kim, MD
4
Departments of 
1Radiology and Research Institute of Radiology, 
3Microbiology, Bio-Medical Institute Technology, and 
4Colorectal Surgery, Asan 
Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Korea; 
2Department of Radiology & Imaging, Queen Elizabeth Hospital, 
Kowloon, Hong Kong
Objective: To evaluate the safety and effectiveness of a 20-mm diameter dual-design expandable colorectal stent for malignant 
colorectal obstruction. 
Materials and Methods: The study series included 34 patients with malignant colorectal obstruction who underwent 
implantation of a 20-mm dual-design expandable colorectal stent in our department between March 2009 and June 2010. 
The 20-mm dual-design expandable colorectal stent was placed by using a 3.8-mm delivery system that had 28-mm diameter 
proximal and distal ends. Among the 34 patients, stent placement for palliation was performed in 20 patients, while stent 
placement for bridge to surgery was performed in 14 patients.
Results: A 97% (33 of 34) success rate was achieved for the stent placement. The perforation rate in the bridge to surgery 
group was 7% (1 of 14), compared to 0% (0 of 19) in palliative group. Migration occurred in one of 33 patients (3%) at 30 
days after stent placement.
Conclusion: The placement of a 20-mm diameter dual-design stent appears to be clinically safe and effective for the management 
of colorectal obstruction, with low perforation and migration rates.
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to surgery in patients with primary colorectal cancer (1-6). 
The overall success rate is very high, ranging from 80% to 
100% (7-12). Even though there is a high success rate for 
the stent placement, complications are still encountered. In 
bare stent placement, recurrent obstruction rates of 3-46% 
due to tumor ingrowth have been reported (7, 12, 13). 
Reported recurrent obstruction rates due to tumor ingrowth 
have been reduced to 0-7% with the use of covered 
expandable metal stents (14, 15). Although covered stents 
have proven to be effective for the occlusion of fistulas or 
ruptures in the gastrointestinal tract (14, 16), their use 
has been plagued by stent migration problems. While the 
migration rates associated with bare stent placement have 
ranged from 3% to 12% (11, 13, 17), the overall migration 
rates of covered stents have been reported to be as high as 
30% to 50% (14, 15, 18).
http://dx.doi.org/10.3348/kjr.2012.13.1.66
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To overcome migration of the stent and tumor ingrowth, 
a dual-design expandable colorectal stent has been 
devised (1). Even though the dual design stent has a low 
tumor ingrowth rate (3%) and migration rate (3%), the 
perforation rate is still reported to be 11%, mainly due to 
upper flared ends of the stent (1). In order to decrease 
the perforation rate of dual-design stents, Kim et al. (19) 
designed a study to test the hypothesis that a dual-design 
colorectal stent with bent ends had lower risk of causing 
colonic perforations than a dual-design stent with flared 
ends. However, the rates of colonic perforation did not 
differ significantly between stent types, nor did the rate 
of stent-related mortality. In addition, the two stent types 
had similar technical and clinical success as well as stent 
migration rates (19). 
We hypothesized that a dual stent with a smaller 
diameter could decrease the rate of perforation due to the 
low expansion force and better conformability; therefore, 
placing a smaller diameter stent may be a safe and effective 
strategy in treating a colorectal obstruction. The aim of 
this prospective study was to report the clinical results of 




Informed consent for placement of 20-mm dual-design 
expandable colorectal stents was obtained for each 
patient, and our Institutional Review Board approved this 
prospective study.
Demographic details of all 34 patients are summarized in 
Table 1. This prospective non-randomized study involved 
34 patients with a malignant colorectal obstruction 
and who were implantated with a 20-mm dual-design 
expandable colorectal stent in our department between 
March 2009 and June 2010. The 34 patients consisted of 
19 male and 15 female patients ranging in age from 37 
to 86 (mean, 59.7) years. Among the 34 patients, stent 
placement for palliation was performed in 20 patients, 
while stent placement for bridge to surgery was performed 
in 14 patients. The indication of palliative stent placement 
in patents was to relieve bowel obstruction. Inclusion 
criteria for stent placement were as follows: 1) documented 
malignancy and 2) bowel obstruction as defined by 
symptoms resulting in defecation difficulty. Exclusion 
criteria included asymptomatic patients with malignant 
colorectal obstruction and who showed clinical evidence of 
perforation or colorectal obstruction combined with small 
bowel obstructions. Data collected included demographic 
information, causes of malignancy, sites and length of 
obstruction, indications for stent placement, symptom 
improvement after stent placement, procedure or stent-
related complications, management of complications, and 
expansion of stents. 
The underlying causes of obstruction were colorectal 
carcinoma in 32 patients, ovarian carcinoma in one 
patient, and metastatic carcinoma of the stomach in one 
patient. The sites of obstruction included the rectum in 
five patients, rectosigmoid in three patients, sigmoid in 20 
patients, descending colon in three patients, transverse colon 
in one patient, and ascending colon in two patients. The 
lengths of stricture ranged from 3 cm to 10 cm (mean, 5.0 cm). 
Stents and Stent Introducer Sets
The 20-mm dual stent (S&G Biotech, Seongnam, Korea) 
consisted of an outer stent and an inner bare nitinol 
stent (Fig. 1). The outer stent consisted of three parts: a 
proximal bare nitinol stent (diameter, 28 mm; length, 25 
mm), a nylon mesh (diameter, 20 mm), and a distal bare 
nitinol stent (diameter, 28 mm; length, 25 mm). The inner 
bare nitinol stent was 20 mm in diameter. The total length 
of the inner stent was the same as that of the outer stent. 
The expansion force of the stent was 2.42-N (Newton) in 
the middle and 1.92-N at both ends. For the previously 
used 24-mm dual stent, the expansion force was 2.96-N in 
the middle and 3.60-N at both ends. The expansion force 
was measured by LR5K PLUS testing machine (AMETEK 
LLOYD, England). The new inner bare stent could easily be 
bent without a decrease in the luminal diameter (Fig. 1). 
The conformability of the inner stent is attributed to the 
thinner wire used. Previously, the 24-mm inner stent was 
made of a 0.254-mm wire, but now the new 20-mm inner 
stent is made of 0.203-mm wire. The delivery system is also 
smaller for the new stent compared with the 24-mm inner 
stent, which now is only 3.8 mm, while it was previously 4.5 
mm. With the smaller delivery system and more conformable 
stent, the new stent could be delivered even in the most 
adverse situations. 
The S&G Biotech stent introducer system consisted of a 
Teflon sheath, 3.8 mm in outer diameter and 80-150 cm in 
length, a pusher coil catheter, and a guiding olive tip. The 
outer and inner stents were loaded in their own separate 
delivery systems. Korean J Radiol 13(1), Jan/Feb 2012 kjronline.org 68
Chou et al.
Stent Placement Technique
The details of dual stent placement have been described 
previously (1). Briefly, with the patient in the left lateral 
decubitus position, a 0.035-inch guidewire (Radiofocus 
M, Terumo, Tokyo, Japan) was inserted under fluoroscopic 
guidance through the anus, across the obstruction, and into 
the proximal region of the obstruction. After the guidewire 
was exchanged for a superstiff, 260-cm-long Amplatz 
guidewire (Medi-tech, Boston Scientific, Boston, MA), the 
stent delivery system containing the outer component of 
the stent was passed over the superstiff guidewire, through 
the obstruction, until the proximal stent had passed 
through the obstruction. The pusher catheter was held in 
place, while the sheath was slowly withdrawn, and deployed 
across the stent stricture. The stent delivery system was 
removed with the superstiff guidewire left in place. A stent 
delivery system containing the inner bare component of the 
stent was then advanced over the superstiff guidewire to 
Table 1. Demographic Details of All Patients
Patient Sex Age Site of Obstruction Diagnosis Indication Complication Immediate Remedy
1 F 52 Rectum Ovarian cancer Palliation None
2 M 81 Ascending colon Colorectal cancer Palliation None
3 M 49 Descending colon Colorectal cancer Palliation None
4 M 54 Sigmoid colon Colorectal cancer Palliation Incomplete expansion Balloon dilatation
5 F 37 Sigmoid colon Colorectal cancer Palliation None
6 M 51 Sigmoid colon Colorectal cancer Palliation None
7 M 63 Sigmoid colon Colorectal cancer Palliation None
8 F 47 Sigmoid colon Colorectal cancer Bridge to surgery Incomplete expansion Balloon dilatation
9 M 51 Sigmoid colon Colorectal cancer Bridge to surgery Incomplete expansion Balloon dilatation
10 M 70 Sigmoid colon Colorectal cancer Palliation Incomplete expansion Balloon dilatation
11 F 60 Sigmoid colon Colorectal cancer Palliation None
12 M 65 Rectum Colorectal cancer Bridge to surgery None
13 M 37 Rectum Colorectal cancer Palliation Incomplete expansion Balloon dilatation
14 M 61 Transverse colon Colorectal cancer Palliation Incomplete expansion Balloon dilatation
15 M 68 Recto-sigmoid Colorectal cancer Palliation None
16 M 67 Descending colon Colorectal cancer Bridge to surgery None
17 F 68 Recto-sigmoid Colorectal cancer Bridge to surgery None
18 M 73 Sigmoid colon Colorectal cancer Bridge to surgery None
19 M 64 Rectum Colorectal cancer Bridge to surgery None
20 F 55 Sigmoid colon Colorectal cancer Bridge to surgery Perforation Operation
21 F 55 Sigmoid colon Colorectal cancer Bridge to surgery None
22 F 38 Sigmoid colon Colorectal cancer Palliation None
23 M 69 Sigmoid colon Colorectal cancer Palliation None
24 F 46 Recto-sigmoid Colorectal cancer Bridge to surgery None
25 F 62 Sigmoid colon Colorectal cancer Bridge to surgery None
26 F 49 Sigmoid colon Colorectal cancer Palliation Fail Operation
27 F 86 Ascending colon Colorectal cancer Palliation None
28 F 68 Sigmoid colon Colorectal cancer Bridge to surgery None
29 M 61 Descending colon Colorectal cancer Bridge to surgery None
30 F 58 Sigmoid colon Colorectal cancer Bridge to surgery None
31 M 67 Rectum Stomach cancer Palliation None
32 M 54 Sigmoid colon Colorectal cancer Palliation None
33 M 65 Sigmoid colon Colorectal cancer Palliation None
34 F 78 Sigmoid colon Colorectal cancer Palliation None
Note.— F = female, M = maleKorean J Radiol 13(1), Jan/Feb 2012 kjronline.org 69
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place the inner bare component coaxially into the outer stent.
Follow Up
Patients underwent a plain abdominal radiographic 
examination and a barium study 1 to 3 days after stent 
placement to assess the expansion and patency of the stent 
as well as possible complications. Patients for palliation also 
underwent a barium study one month after stent placement 
to verify delayed complications, such as stent migration or 
obstruction. Further follow-up in each patient was based on 
monthly plain radiography and clinical examinations in the 
outpatient clinic. A follow-up barium study or endoscopy 
was performed only in patients with recurrent symptoms. 
When the performance of clinical examinations was not 
practical, the patients or their families were contacted by 
telephone every month until their death. Information was 
obtained concerning defecation difficulty.
Interpretation of the Results
Clinical success was defined as relief of bowel obstruction. 
Tumor overgrowth was defined as symptomatic narrowing 
of the stent lumen above or below the covered portion of 
the stents as a result of tumor growth. Tumor ingrowth 
was defined as symptomatic narrowing of the stent lumen 
within the covered portion of the dual stent. Complications 
including bleeding, pain, tumor overgrowth or ingrowth, 
perforation, migration, and symptom recurrence were evaluated.
RESULTS
The collective technical and clinical success rate of 
stent placement was 97% (33 of 34). The only failure case 
was a 49-year-old lady suffering from a sigmoid colon 
obstruction due to underlying colorectal carcinoma. The 
colonic carcinoma caused by complete obstruction of the 
sigmoid colon, with failure to cross the obstruction with 
the guide wire. She proceeded to operation right after stent 
placement failure.
A total of 33 stents were placed at the time of the initial 
stent placement in the 33 patients with successful stent 
placement (Fig. 2): all patients required only one stent to 
traverse the site of the obstruction. In six of 33 patients 
(18%), dilatation of the dual stent using a 14-mm balloon 
catheter was performed after insertion of the inner bare 
stent because the diameter of the both placed stent was 
less than a third of the preset expanded diameter (20 mm).
In all the successful stent placement patients, there was 
no symptom recurrence until the date of this article was 
revised (July 2011). The follow-up period ranged from 12 
days to 760 days (mean, 335.7 days; median, 297.5 days; 
standard deviation, 259.1 days). Perforation occurred in one 
patient two days after stent placement. The perforation rate 
for the bridge to surgery group was 7% (1 of 14), compared 
to 0% (0 of 19) for the palliative group. The patient with 
a perforation suffered from obstructive sigmoid carcinoma 
and a stent was placed as a bridge to surgery. An emergency 
colectomy was performed for this patient. The perforation 
site was at the proximal end of the stent. After nine months 
of follow up, the patient still performed well without any 
complication or sign of recurrence.
Migration occurred in one of 33 patients (3%) at 30 days 
after stent placement. The patient with stent migration 
was a 37-year-old female suffering from obstructive 
sigmoid carcinoma. The stent was placed for palliation and 
subsequently underwent chemotherapy and radiotherapy. 
The stent was expelled spontaneously one month after 
chemoradiation.
We did not encounter any tumor ingrowth or overgrowth 
in this study.
DISCUSSION
Recently, colorectal metallic stenting has been performed 
in lieu of a colostomy for patients that are good candidates 
for curative surgery to allow time for preoperative bowel 
Fig. 1. Photograph showing, from top to bottom, outer stent of 
dual stent, inner bare nitinol stent of dual stent, and bended 
inner bare nitinol stent.Korean J Radiol 13(1), Jan/Feb 2012 kjronline.org 70
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preparation (13, 20-22). Placement of an expandable 
metallic stent has also been used as a logical method for 
palliation in patients unsuitable for curative surgery, not 
only because it avoids a palliative colostomy but also 
because it reduces hospital stays (17, 23, 24). In previous 
studies (7-12), there was high success rate in treating 
colorectal obstructions using metallic stents. However, 
problems such as migration and perforation were still 
experienced. 
In our study, our success rate in placing the stent was 
97%. Among all the successful stent placements, one case 
of perforation and one case migration were experienced. 
The perforation rate in the bridge to surgery group was 7% (1 
of 14), compared to 0% (0 of 19) for the palliative group. 
The migration rate was 3% (1 of 33).
The perforation rate was reported to be around 4% 
of patients who are implantated with colorectal self-
expandable metallic stents (8-11), though higher 
perforation rates (16-83%) have also been reported (25-
27). For dual-design expandable metallic stents, the 
perforation rate was reported to be 22% in the bridge to 
surgery group, and 5% in the palliative group (1). Kim et 
al. (19) tried to use a dual-design colorectal stent with 





Fig. 2. Illustration of patient with sigmoid colon cancer (patient 11). 
A. Water-soluble contrast study with sizing coil catheter during stent placement showing incomplete colonic obstruction. B. Plain radiograph obtained 
during placement of dual stent showing loaded distal stent. C. Plain radiograph obtained immediately after outer stent placement with loaded 
inner stent. D. Plain radiograph obtained immediately after stent placement of dual stent showing good flow of contrast medium through stent.Korean J Radiol 13(1), Jan/Feb 2012 kjronline.org 71
Dual-Design Expandable 20-mm Diameter Stent and Malignant Colorectal Obstruction
Given that a small-diameter stent has a lesser expansion 
force (28), the risk of perforation may theoretically be 
reduced. Our study was designed to test the hypothesis that 
a dual-design colorectal stent with smaller a diameter had 
a lower risk of causing colonic perforation. As expected, 
our results indicated that the perforation rate of the new 
stent measuring 20 mm in the middle and 28 mm at both 
ends was lower when compared with the larger diameter 
dual-design stent (24 mm in the middle and 32 mm at 
both ends). For this new 20-mm dual-design stent, the 
perforation rate for the bridge to surgery group was only 7%, 
which was much lower than the 22% previously reported 
using the larger diameter dual-design stent (1). Even more, 
the perforation rate for the palliative group attained 0% 
(0 of 19). The lower perforation rate decreased patient 
mortality and morbidity.
Migration is another problem for colorectal stenting. The 
reported migration rates range from 3-12% for the bare 
metallic stent (11, 13, 17) and 30-50% for the covered 
stent (14, 16). After employing the newly invented dual-
design expandable metallic stent, a significant drop in 
migration rate was observed. The recent reported migration 
rate for the 24-mm diameter stent was 3% (1). In our study, 
even though we used a 20-mm diameter stent, which was 
expected to have less expansion force (28), we encountered 
only one case of migration among the 33 stent placements 
(3%). For this migration case, it was a case of 37-year-old 
suffering from obstructive sigmoid carcinoma. The stent 
was put in for palliative purposes. After placement of the 
stent, the patient underwent through chemotherapy and 
radiotherapy. We believed that the stent migration was due 
to the shrinkage of tumor caused by the chemoradiation.
Our study has several limitations. First, the study was 
not performed in a randomized manner. Second, the study 
included a small number of patients. Third, the follow-up 
duration for some of the patients was relatively short due 
to the death of terminal cases.
In conclusion, 20-mm diameter stent placement seems to 
be clinically safe and effective in patients with a colorectal 
obstruction, with low perforation and migration rates. 
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